DFC 004 Biomarkers for Active Diabetic Foot Ulcers | MicrobiomeTrials← Back to trialsNCT06104969
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-06-15Est. Completion: 2028-06-15
Enrollment target: 5,000 participants Locations- University of Arizona College of Medicine, Tucson, Arizona, United States
- University of Southern California, Los Angeles, California, United States
- University of California - San Francisco, San Francisco, California, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Northwell Health, Lake Success, New York, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
- University of Texas Health San Antonio, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Type 2 Diabetes Mellitus (T2DM)
This randomized controlled trial will evaluate the effect of digital-supported foot care education on foot care knowledg…
Siirt, Turkey (Türkiye)Est. completion Jul 15, 2027
Diabetic Foot Ulcer (DFU)
This is a randomized controlled clinical investigation in patients suffering from diabetic foot ulcers at multiple centr…
Dhaka, BangladeshEst. completion Feb 2027
Chronic Ulcers of the Lower Limb
The purpose of this study is to evaluate the safety and clinical performance of transverse tibial bone transport in pati…
Jacksonville, United StatesEst. completion Jul 31, 2027